CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 494 of 494 entries

View as:

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Phase: N/A Priority: Normal

NCT ID: NCT03745820 Org: User:

Start: 11/15/18 End: 04/07/22 Due: 04/07/23

Study of Utilization Patterns of Dimethyl Fumarate in Germany

Phase: N/A Priority: Normal

NCT ID: NCT02969304 Org: User:

Start: 12/30/16 End: 03/02/17 Due: 03/02/18

Fampridine Pregnancy Exposure Registry

Phase: N/A Priority: Normal

NCT ID: NCT01532154 Org: User:

Start: 08/31/15 End: 02/29/16 Due: 02/28/17

Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT02459886 Org: User:

Start: 07/01/15 End: 11/20/17 Due: 11/20/18

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice

Phase: N/A Priority: Normal

NCT ID: NCT01480063 Org: User:

Start: 04/16/12 End: 02/08/19 Due: 02/08/20

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Phase: N/A Priority: Normal

NCT ID: NCT02036970 Org: User:

Start: 05/31/14 End: 05/16/18 Due: 05/16/19

A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants

Phase: N/A Priority: Normal

NCT ID: NCT02829541 Org: User:

Start: 08/31/16 End: 12/31/16 Due: 12/31/17

A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01943513 Org: User:

Start: 10/31/13 End: 05/31/14 Due: 05/31/15

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

Phase: N/A Priority: Normal

NCT ID: NCT02137109 Org: User:

Start: 03/31/14 End: 10/31/15 Due: 10/31/16

Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy

Phase: N/A Priority: Normal

NCT ID: NCT04106050 Org: User:

Start: 09/30/20 End: 01/21/22 Due: 01/21/23

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Phase: N/A Priority: Normal

NCT ID: NCT02657356 Org: User:

Start: 10/04/16 End: 05/07/20 Due: 05/07/21

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT05310071 Org: User:

Start: 06/02/22 End: 08/12/24 Due: 08/12/25

Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases

Phase: N/A Priority: Normal

NCT ID: NCT00107861 Org: User:

Start: 05/31/05 End: 09/30/06 Due: 09/30/07

Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01551446 Org: User:

Start: 04/30/12 End: 11/30/12 Due: 11/30/13

A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl

Phase: N/A Priority: Normal

NCT ID: NCT01461161 Org: User:

Start: 10/31/11 End: 12/31/11 Due: 12/31/12

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT01655186 Org: User:

Start: 09/30/12 End: 10/31/12 Due: 10/31/13

Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Phase: N/A Priority: Normal

NCT ID: NCT01903291 Org: User:

Start: 08/31/13 End: 02/29/16 Due: 02/28/17

Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00529113 Org: User:

Start: 09/30/07 End: 11/01/09 Due: 11/01/10

An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01598363 Org: User:

Start: 06/30/12 End: 07/31/12 Due: 07/31/13

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)	NCT03745820	Biogen	user2@example.com	None	2018-11-15	2022-04-07	2023-04-07	-	-	2025-07-14
Study of Utilization Patterns of Dimethyl Fumarate in Germany	NCT02969304	Biogen	user2@example.com	None	2016-12-30	2017-03-02	2018-03-02	-	-	2025-07-14
Fampridine Pregnancy Exposure Registry	NCT01532154	Biogen	user2@example.com	None	2015-08-31	2016-02-29	2017-02-28	-	-	2025-07-14
Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease	NCT02459886	Biogen	user2@example.com	None	2015-07-01	2017-11-20	2018-11-20	-	-	2025-07-14
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice	NCT01480063	Biogen	user2@example.com	None	2012-04-16	2019-02-08	2020-02-08	-	-	2025-07-14
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT	NCT02036970	Biogen	user2@example.com	None	2014-05-31	2018-05-16	2019-05-16	-	-	2025-07-14
A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants	NCT02829541	Biogen	user2@example.com	None	2016-08-31	2016-12-31	2017-12-31	-	-	2025-07-14
A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers	NCT01943513	Biogen	user2@example.com	None	2013-10-31	2014-05-31	2015-05-31	-	-	2025-07-14
Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri	NCT02137109	Biogen	user2@example.com	None	2014-03-31	2015-10-31	2016-10-31	-	-	2025-07-14
Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy	NCT04106050	Biogen	user2@example.com	None	2020-09-30	2022-01-21	2023-01-21	-	-	2025-07-14
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST	NCT02657356	Biogen	user2@example.com	None	2016-10-04	2020-05-07	2021-05-07	-	-	2025-07-14
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease	NCT05310071	Biogen	user2@example.com	None	2022-06-02	2024-08-12	2025-08-12	-	-	2025-07-14
Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases	NCT00107861	Biogen	user2@example.com	None	2005-05-31	2006-09-30	2007-09-30	-	-	2025-07-14
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes	NCT01551446	Biogen	user2@example.com	None	2012-04-30	2012-11-30	2013-11-30	-	-	2025-07-14
A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl	NCT01461161	Biogen	user2@example.com	None	2011-10-31	2011-12-31	2012-12-31	-	-	2025-07-14
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus	NCT01655186	Biogen	user2@example.com	None	2012-09-30	2012-10-31	2013-10-31	-	-	2025-07-14
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS	NCT01903291	Biogen	user2@example.com	None	2013-08-31	2016-02-29	2017-02-28	-	-	2025-07-14
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer	NCT00529113	Biogen	user2@example.com	None	2007-09-30	2009-11-01	2010-11-01	-	-	2025-07-14
An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers	NCT01598363	Biogen	user2@example.com	None	2012-06-30	2012-07-31	2013-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance